Name | Moxifloxacin Hydrochloride |
Purity | 99.0% min. |
Appearance | Light yellow or yellow powder or crystals |
Synonym | 1-cyclopropyl-7-[(1S,6S)-2,8-diazabicyclo [4.3.0]non-8-yl]-6-fluoro-8-methoxy-4-oxo- quinoline-3-carboxylic hydrochloride acid |
CAS No. | Moxifloxacin Hydrochloride has the CAS number being 186826-86-8 |
Molecular Formula | Moxifloxacin Hydrochloride has the molecular formula being C21H25ClFN3O4 |
Molecular Weight | Moxifloxacin Hydrochloride has the molecular weight being 437.89 |
Structure |  |
Product Introduction (CAS 186826-86-8) | Moxifloxacin Hydrochloride (CAS 186826-86-8) can be used in treatment of acute bacterial sinusitis, acute bacterial exacerbation of chronic bronchitis, non-severe community-acquired pneumonia, complicated and uncomplicated skin and skin structure infections, and complicated intra-abdominal infections and acute bacterial sinusitis. Moxifloxacin Hydrochloride (CAS 186826-86-8) has been formulated into finished dosage forms and marketed worldwide under the brand names Avelox, Avalox, and Avelon for oral treatment. It is also sold in an ophthalmic solution (eye drops) under the brand names Vigamox, Moxeza for the treatment of conjunctivitis (pink eye). Moxifloxacin Hydrochloride (CAS 186826-86-8) is one API approved in treating infections including: respiratory tract infections, cellulitis, anthrax, intraabdominal infections, endocarditis, meningitis, and tuberculosis. |
Product Quality (CAS 186826-86-8) | Our professional scientists have studied thecharacteristic specifications of Moxifloxacin Hydrochloride (CAS 186826-86-8), including appearance, identification, assay, related substances, residual solvents and so on. Our Moxifloxacin Hydrochloride (CAS 186826-86-8) API is manufactured according to Ph.Eur. standards. For more detailed COA, please reach us through following contact information. |
HEC production status (CAS 186826-86-8) | Moxifloxacin Hydrochloride (CAS 186826-86-8) is commercial available in HEC pharm after its patent expiration. Right now, we have finished its DMF/CEP registration with the published number being CEP2013-225 and DMF27394. And we are compiling its other registration documents, such as J-DMF HEC pharm is a qualified pharmaceutical manufacturer with headquarter based in Guangdong, China. We have cGMP/ICH compatible quality management system and facilities audited by FDA/EU/TGA/WHO and other authorities. For our specific GMP certificates, please reach us through following contact information. |
HEC contact information (CAS 186826-86-8) | If you are looking for suppliers of Moxifloxacin Hydrochloride (CAS 186826-86-8), HEC pharm would be your reliable API supplier with intact regulatory support and reasonable market price. Should you have interest in our Moxifloxacin Hydrochloride (CAS 186826-86-8), please feel free to contact us at sales@hecpharm.com |